New balloon zaps heart cells to stop AFib – first human trial underway

NCT ID NCT07320976

First seen Jan 11, 2026 · Last updated May 01, 2026 · Updated 14 times

Summary

This early study tests a new balloon catheter that uses short bursts of electrical energy (pulsed-field ablation) to treat atrial fibrillation, a common heart rhythm problem. The balloon is shaped to fit the veins that carry blood from the lungs to the heart, and it aims to safely block the faulty signals that cause AFib. 35 adults with paroxysmal (come-and-go) AFib will receive the procedure and be followed for one year to check safety and how well it works.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PAROXYSMAL ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • The Third People's Hospital of Chengdu

    Chengdu, Sichuan, China

Conditions

Explore the condition pages connected to this study.